124 results
Page 5 of 7
8-K
EX-3.1
mjrti9 t6tvryx
13 Apr 17
Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering
12:00am
424B4
ft60dg2cqe7 3tpsn24m
10 Apr 17
Prospectus supplement with pricing info
12:00am
425
EX-2.1
k7w cok8i6spq9xs
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-2.1
nm0zyk dthamn
6 Mar 15
Targacept and Catalyst Biosciences Enter Definitive Merger Agreement Creating a Protease-Based Hemostasis and Anti-Complement Company
12:00am
8-K
EX-99.1
hny8c0ip
6 Mar 15
Regulation FD Disclosure
12:00am
425
EX-99.1
pu8xzgm3ywos
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-10.1
n11a56pysbep5a
26 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
mdqq l2ztfuaqw
1 Nov 11
Targacept Reports Third Quarter 2011 Financial Results
12:00am